OptiBiotix Health raises GBP1.4 million to invest in "driving sales"
(Alliance News) - OptiBiotix Health PLC on Monday said it has raised GBP1.4 million through a placing and subscription of shares.
Read moreTue, 17th Mar 2020 15:49
(Alliance News) - OptiBiotix Health PLC on Monday said it has raised GBP1.4 million through a placing and subscription of shares.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Life science company OptiBiotix Health announced the signing of a partnership agreement with Dr Morepen on Wednesday, for the distribution of SlimBiome products in India under the Dr Morepen brand.
Read more(Alliance News) - OptiBiotix Health PLC shares rose on Tuesday as the firm celebrated a "gradual return to strong sales growth".
Read moreOptiBiotix Health PLC - York, England-based life sciences company - Hails "significant progress" in SweetBiotix commercial scale production. Says it is currently in discussions with commercial partners to launch SweetBiotix products. SweetBiotix is a low calorie alternative to sugar. Chief Executive Officer Stephen O'Hara says: "Consumer concerns over sugar and the safety of several sugar substitutes have materialised into companies reformulating existing and/or launching new products containing natural, safe, and healthy alternatives. The company believes its sweet, high fibre, low calorie, prebiotic fibre SweetBiotix products are ideally positioned to launch at a time when many companies are actively looking for a natural alternative to meet this need."
Read more(Sharecast News) - OptiBiotix Health announced the upcoming launch of LeanBiome in partnership with prominent sports nutrition brand Muscletech on Monday.
Read more(Alliance News) - OptiBiotix Health PLC on Monday announced the launch of LeanBiome in sports nutrition brand, MuscleTech.
Read moreOptiBiotix Health PLC - York, England-based life sciences company - Appoints Graham Myers as finance director, effective as of December 1, 2023. Says that Myers' appointment to this part-time role will see him work closely with the OptiBiotix team to support its focus on "driving each business unit and the group to profitability". Myers is currently chair of Croda Pension Trustees Ltd, the sole trustee of Croda International PLC's GBP800 million UK pension scheme.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - OptiBiotix Health reported significant progress in its commercial endeavours in an update on Wednesday, as it looked to attain profitability at the business unit level, ultimately leading to overall profitability.
Read more(Alliance News) - OptiBiotix Health PLC on Wednesday said sales from existing partners have improved in recent months, and that its move to focus on US and Asian markets is progressing well.
Read more(Alliance News) - OptiBiotix Health PLC on Monday said it agreed a licence deal with Tata Chemicals Ltd to incorporate Tata's short-chain fructo-oligosaccharide Fossence into OptiBiotix's SlimBiome and LeanBiome products for the Indian market.
Read more(Sharecast News) - Life sciences developer OptiBiotix Health announced a significant agreement with Tata Chemicals on Monday, that would see its proprietary 'Fossence' product incorporated into their 'SlimBiome' and 'LeanBiome' product lines, specifically tailored for the Indian market.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more